Norton Scientific now trading on Frankfurt Stock Exchange

(Thorold) — Norton Scientific, currently marketing the renowned and award-winning PAM Protein Aggregation Monitor, is proud to announce its stock is now trading as of June 3 on the First Quotation Board (Open Market) of the Frankfurt Stock Exchange.  Norton’s trading symbol is NT3 and was assigned last month by Deutsche Börse.

“Since the beginning the response has been phenomenal,” says Bryan Webb, President of Norton.  “We’re excited to begin the next stage of growth and discovery.”

The PAM Zero is a small, low cost device that can measure aggregate content in as little as 2μl of sample in a matter of seconds, making it an invaluable screening tool in a variety of sample preparatIon applications including crystal structure determination and mass spectroscopy.  It is also capable of following aggregation reactions in real time without any concerns about fluorescent tagging altering the observed behaviour.

Based in the Niagara Region of Canada, Norton Scientific was established in 2010 to take the knowledge and experience of the founders dating back two decades in the analysis of complex macromolecular and nano-particulate materials and to design innovative measurement tools for use by bench scientists working in modern research facilities.

Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials, and in-water pollution monitoring.